Literature DB >> 11421178

HIV surveillance among injecting drug users.

D C Des Jarlais1, K Dehne, J Casabona.   

Abstract

Injecting drug users (IDUs) should be considered a 'partially hidden population' at high risk for HIV infection. In almost all locations it should be possible to locate and conduct research with IDUs, but it will probably never be possible to enumerate or draw random samples from an IDU population. Surveillance research studies with IDUs should include risk behaviors, as surveillance of HIV infection only will not be sufficiently time sensitive, and be used to develop and refine HIV prevention programming for the population. Contacts with IDUs can be developed at multiple settings, including voluntary treatment programs, law enforcement settings, and through 'street outreach.' Each type of setting has different advantages, disadvantages and ethical concerns. HIV testing as part of surveillance also raises additional important ethical concerns. The primary risk behaviors that should be included in surveillance studies are 'sharing' of drug injection equipment, the potential for rapid partner change among risk partners, and sexual risk behavior. Additional important objectives for surveillance research include: (1) the size of the local IDU population, (2) patterns of drug use, (3) availability injection equipment, (4) participation in prevention activities, and (5) access to and use of anti-retroviral treatments. HIV incidence is an ultimate objective for surveillance research, but there are no currently available cost-efficient methods for studying HIV incidence, so estimation from indirect measurements is usually required.

Entities:  

Mesh:

Year:  2001        PMID: 11421178     DOI: 10.1097/00002030-200104003-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Increasing prevalence of cocaine as the primary detoxification diagnosis among admissions presenting with current intravenous drug use: a review of detoxification records from northern British Columbia, 1999-2005.

Authors:  Russell C Callaghan; Carol Strike; Thomas Kerr; Benedikt Fischer; Jane Buxton; Emma Stevens; Lawren Taylor; J Charles Victor
Journal:  Can J Public Health       Date:  2008 May-Jun

2.  Mental health in HIV seronegative and seropositive IDUs in South Florida.

Authors:  Deborah L Jones; Drenna Waldrop-Valverde; Peggy Gonzalez; Alison Mack; Adarsh M Kumar; Ray Ownby; Stephen M Weiss; Mahendra Kumar
Journal:  AIDS Care       Date:  2010-02

3.  Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.

Authors:  Waleska Teixeira Caiaffa; Sueli Aparecida Mingoti; Fernando A Proietti; Anna Bárbara Carneiro-Proietti; Rodrigo Carazolli Silva; Aline Cristine Souza Lopes; Denise Doneda
Journal:  J Urban Health       Date:  2003-03       Impact factor: 3.671

4.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

5.  Reducing HIV risks among active injection drug and crack users: the safety counts program.

Authors:  Mary Jane Rotheram-Borus; Fen Rhodes; Katherine Desmond; Robert E Weiss
Journal:  AIDS Behav       Date:  2009-09-11

6.  Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.

Authors:  Kathleen Falster; John M Kaldor; Lisa Maher
Journal:  J Urban Health       Date:  2008-11-01       Impact factor: 3.671

7.  Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco.

Authors:  Alex H Kral; Mohsen Malekinejad; Jason Vaudrey; Alexis N Martinez; Jennifer Lorvick; Willi McFarland; H Fisher Raymond
Journal:  J Urban Health       Date:  2010-09       Impact factor: 3.671

8.  The rise of injecting drug use in East Africa: a case study from Kenya.

Authors:  Susan Beckerleg; Maggie Telfer; Gillian Lewando Hundt
Journal:  Harm Reduct J       Date:  2005-08-25

9.  Estimation of the Frequency of Intravenous Drug Users in Hamadan City, Iran, Using the Capture-recapture Method.

Authors:  Salman Khazaei; Jalal Poorolajal; Hossein Mahjub; Nader Esmailnasab; Mohammad Mirzaei
Journal:  Epidemiol Health       Date:  2012-10-31

10.  Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence.

Authors:  Georgiy Bobashev; Sarah Mars; Nicholas Murphy; Clinton Dreisbach; William Zule; Daniel Ciccarone
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.